Get complete information related to latest Blade Plate Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Blade Plate Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Blade Plate Tenders.
Tender For orthopedics implants and other material purchase in dh raisen - ortho implants and other materials, interlocking nail for tibia- all sizes with 4 lockingbolt set, expert tibial nailing system (titanium) all sizessystem with all bolts set, distal tibia nail - all sizes with 4 locking bolt set, interlocking nail for femur - all sizes with 4 lockingbolt set, supracondylar nail - all sizes with 4 locking bolt set, distal femur nail multilock all sizes with locking bolts, proximal femur nail all sizes with all locking bolts -short and long, proximal femur nail a2 (stainless steel) - shortpfn /long pfn all sizes with locking bolt set, proximal femur nail a2 (titanium) - short pfn /long pfn all sizes with locking bolt set, proximal humerus multi lock nail- all sizes withlocking bolts, interlocking humers nail- all sizes with 4 locking boltset, k nail for femur- all sizes set, square nail radius with screw set (all sizes set), square nail ulna all sizes set, rush nail all sizes set, enders nail all diameter & sizes set, titanium elastic nailing system (tens)-all size (dia.2mm,2.5mm,3mm,3.5mm,4mm,4.5mm)(length 44 cm), ao trauma mini set - stainless steel andtitanium, ao trauma small set - stainless steel andtitanium, ao trauma standard set - stainless steel andtitanium, dynamic compression plate (d.c.p.small 3.5mm)radius/ulna complet set with screw, d.c.p.narrow for tibia / humerusall sizes with 4.5cortical screw compleate set, d.c.p.broad (4.5 mm )for femur - all sizes with 4.5cortical screw and screw hole set, l.c.p.plate small (3.5 mm) all sizes with locking screwhole set, l.c.p.plate narrow (4.5 mm) with screw complete set-all sizes, l.c.p.plate broad (4.5 mm) with screw complete set, reconstruction plate non locking 3.5mm- allsizes with 3.5 cortical screw set, reconstruction plate locking 3.5mm - all sizeswith 3.5 cortical screw set, reconstruction platenon non locking 4.5mmwith screw complete set, reconstruction plate locking 4.5mm with screwcomplete set, semi tubular plate 4-12 hole all sizes with screws holeset, one third tubular plate 4-12 hole all sizes withscrews hole set, clavicle lateral end plate with screws set, clavicle hook plate with screws set, clavicle locking precontoured plate 6-10 holewith locking screws set, proximal humerus locking plate (philos) set - 4-12 hole) plate with required locking screw set, distal humerus locking compression plate -medial &lateral(allsize with screw), lcp extraarticular distal humerus metaphyseal locking plate 4 to 12 hole (all size with screw), lcp radial head plate (all size with screw), locking olecrenon plate (all size with screw), hook plate olecranon plate (all sizes withscrews), distal radius locking plates (right / left) 4-8hole, distal radius t plate all sizes with screws, distal radius l plate all sizes with screws, distal radius locking plate variable angle 2.7mm and 2.4 mm system all sizes with screws, distal radius rim plate all sizes, mini plate and screws 1.5mm/ 2mm/ 2.7mm set for metacarpals and phalanges, dhs system with d.h.s.plate (round hole ) angle 125*, 130*, 135*, 140*, 145* short barrel 4-18 hole, long barrel 4- 18 hole, lag screw with compression screw 50-130 mmcortical screw (4.5 mm size 16mm-40mm), d.h.s.with trochanteric support plate with lagscrew comp.setall sizes (4-8 hole) & required cortical screws set, pfn with trochanteric support plate all sizes, proximal femur locking plate all sizes, femoral neck system (fns) all sizes, d.c.s.plate 95* 4 hole to 12 hole, angled bladeplate - all sizes with screws, double angled bladeplate with lag screwall sizes (4-10 holes) with required cortical screws set, pediatric d.h.s.all sizes with 3.5mm cortical screw set, distal femur locking plate (lateral) (dflcp) 6-18hole, proximal tibia locking plate (ptlcp) 6-15 hole, raft locking plate for proximal tibia setall sizes (5-8 hole) with locking screws, l buttress plate right/left all sizes with 4.5cortical screw set, t buttress plate right/left all sizes
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapidexchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of thestent to a major government institute. unit:no [ warranty period: 30 months after the date of delivery ] ]
Tender For empanelment for the supply of cathlab items on running contract basis under kasp and other schemes of this hospital - coronary stents, des,everolimus,fda/dcgi/ce approved platinum chromium platform,polyvinylidene fluride-hexafluropropyline pvdf-hfp polymer-stent lengths8,12,16,24,28,32. stent diameter 2.25*,2.50,2.75,3.00,3.50,4.00.struct thickness 81/86 microns.nominal pressure - 11 atm,rated burst pressure 16-18 atm, des,everolimus,fda/ approved platinum chromium platform,polyvinylidene fluoride-hexafluropropylene(pvdf-hfp)polymer, des,everolimus,fda/dcgi/ce/ approved platinum chromium platform,bioabsorbable polymer plga, everolimus eluting platinum chromium stent system, des, everolimus, l 605 cobalt chromium with hybrid cell design , strut thickness- 65microns, polymer- plga diameter- 2.25, 2.5, 2.75, 3.0, 3.5,4. length- 10,13,15,18,20,24, 28, 32,36,40, 42, 44, des, everolimus, cobalt chromium strut thickness - 63 microns . diameter- 2.25,2.5,2.75,3,3.5,4. length- 8,10,13,15,18,20,24,28,32,36,40,42,44. elutes 80% of drugs along with re plga polymer in the first 20 days, dcgi approved everolimus drug eluting 65 micron strut thickness with 3 micron plla&plga. a unique proprietory coating technology basedbiodegradable polymer stent with open cell designed and flexia finished technology based cobalt chromium l605 stent.a designed for optimal strength, flexibility ,trackablity ,side branch supported,bifurcation supported and high radial strength and optimal radiopacity and excellent vessel supported stent with revers alternative link design(ral) stent, with length from 8 mm to 52 mm and diameter from 2.25 mm to 4.50 mm, ce approved everolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 degree with respect to different diameter. the cells are connected by link (mid to mid pattern) with a radius of 0.2700mm. these values have been validated for lower stent profile, uniform expansion, side branch access, good trackability & strong radial support. components - drug: everolimus, stent platform: cobalt chromium l605 alloy, polymer: biodegradable, catheter: ptca rapid exchange semi-compliant stent delivery catheter. drug concentration: 1.2 microgram/mm2 of stent surface area. stent diameter(mm): 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00 & 4.50 & stent length (mm): 8, 13, 16, 20, 24, 28, 32, 36, 40, 43, 47 platinum-iridium radiopaque markers are precisely placed within the balloon cones for accurate stent positioning, also the difference between stent edge to marker is 0.5mm (atboth sides, proximal & distal) which prevents the dogboning during the angioplasty., ce approved sirolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 degree with respect to different diameter. the cells are connected by link (mid to mid pattern) with a radius of 0.2700mm. these values have been validated for lower stent profile, uniform expansion, side branch access, good trackability & strong radial support. components - drug: everolimus, stent platform: cobalt chromium l605 alloy, polymer: biodegradable, catheter: ptca rapid exchange semi-compliant stent delivery catheter. drug concentration: 1.2 microgram/mm2 of stent surface area. stent diameter(mm): 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00 & 4.50 & stent length (mm): 8, 13, 16, 20, 24, 28, 32, 36, 40, 43, 47 platinum-iridium radiopaque markers are precisely placed within the balloon cones for accurate stent positioning, also the difference between stent edge to marker is 0.5mm (atboth sides, proximal & distal) which prevents the dogboning during the angioplasty., only dcgi approved everolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 deg
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval shouldbe enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent toa major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281215-coronary drug eluting stents (1) with single wire design with cobalt alloy shell and platinum iridium core (2) stent with coating of biolinx polymer carrier for active drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia (3) stent diameter should be from 2 mm to 5mm and length of the stent from 8 mm to 38 mm. (4) the strut should be round with thickness ranging from 81 to 91 microns (5) stent delivery system should be monorail (single operator exchange or rapidexchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) five years efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. ]
Tender For srphc82281210-coronary drug eluting stents (1) single wire technology on cobalt based alloy platform (2) stent with coating of biolinx polymer carrier for active drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.25 mm to 4 mm and length of the stent from 12mm to 38 mm. (4) the strut thickness should be 81 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) five years long term efficacy and safety of the stent in terms of target vesselrevascularisation (tvr) and in-situ thrombosis (ist) should be documented / published inpeer reviewed scientific journals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281275-des-abbreviated dapt long -coronary drug eluting stents with (1) platinum chromium alloy (2) coating of bioabsorbable polymer carrier for activedrug everolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm. the length of the stent should be from 12mm to 48 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (three month) dual antiplatelet therapy for high bleeding risk patients should be documented in peer reviewed journals. (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ).[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281225-coronary drug eluting stents with (1) cobalt chromium alloy (2) coating of bioabsorbable polymer carrier with abluminal and gradient coating foractive drug shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm . the length of the stent should be from 12mm to 38 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should bemonorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (one month) dual antiplatelet therapy for high bleedingrisk patients should be documented in peer reviewed journals. (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ).[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]